Munguva pfupi yapfuura, Center for Drug Evaluation (CDE) yeChina National Medical Products Administration yakabvumidza zviri pamutemo jekiseni reKSD-101, rakagadzirwa naKousai, kuti riiswe mumiedzo yekiriniki. Izvi hazvingoratidzi chete jekiseni rekutanga re dendritic cell (DC vaccine) muChina rakatenderwa neFDA IND asiwo rekutanga rerudzi rwaro muChina rakatenderwa neFast Track Designation (FTD) neUS Food and Drug Administration. Ichi chiitiko chikuru chinoratidza nguva itsva mukurapa kwemuviri wemunhu wega wega bundu reropa rinobatanidzwa neEBV.
KSD-101 ndiyo yekutanga mushonga wekudzivirira chirwere cheDC wakagadzirwa neKousai Biotechnology zvichibva papuratifomu yayo yetekinoroji ye "Eco-DC Vax" yakazvigadzira, uye ndiyo yekutanga mushonga wekudzivirira chirwere cheDC muChina kugamuchira mvumo yeFDA IND. Maitiro ayo anosanganisira kugadzirira mushonga wekudzivirira chirwere wega wega nekuunganidza masero emuviri emurwere, zvichiita kuti asiyane kuita masero e dendritic in vitro, uye kuaisa muEBV-related specific complex antigens. Mushure mekunge mushonga wadzoserwa mumuviri wemurwere, unogona kunyatsoita kuti immune system yemurwere ikwanise kuziva nekuuraya masero egomarara ane maantigen eEBV, ukuwo uchigadzira ndangariro yekudzivirira chirwere chegomarara inogara kwenguva refu.
### Ruzivo Runoshamisa rwezvekurapa: Humbowo hwekutanga hwekuchengetedzwa uye kushanda zvakanaka
Kugona kweKSD-101 kwakasimbiswa pakutanga muzvidzidzo zvekare zvekiriniki. Muchidzidzo chekiriniki chePhase I cheKSD-101 senzira imwe chete yekurapa bundu reropa rinodzokororwa uye risingadzoreki reEBV, chiyero chekupindura chakanangana (ORR) chakasvika pa91.67%, nechiyero chekuregererwa chakazara (CR) che83.33% uye chiyero chekudzora chirwere (DCR) che100%. Kurapa kwakaratidzawo mhinduro dzinogara kwenguva refu uye chimiro chekuchengetedza chakanaka. Ruzivo urwu rwunoshamisa runopa rutsigiro rwakasimba rwekukosha kwekiriniki kweKSD-101.
### Sei Uchifanira Kusarudza China Yekurapa Kwemhando Yepamusoro?
China iri kufambira mberi nekukurumidza mukutsvaga kwekiriniki uye kushandiswa kweminda yemazuva ano yakadai sekurapa nemasero uye immunotherapy. Dhipatimendi reInternational Department reBeijing South Region Oncology Hospital rakatsaurira kubatanidza varwere vepasi rose netekinoroji yekurapa yazvino uye mikana yekuedza kwekiriniki. Kufambira mberi nekukurumidza kweKSD-101 muChina zvinoreva kuti varwere vepasi rose vanogona kuwana kurapwa uku kwakakura nekukurumidza.
### Taura Nesu Kuti Uwane Ruzivo Rwakawanda kana Kuti Uongorore Kukodzera
Kana iwe kana mumwe munhu waunoda akakanganiswa neEBV-associated hematologic bundu (rakadai selymphoma refractory to standard treatment kana CAEBV) uye achifarira throughtuff therapy KSD-101, tinokukokai nemwoyo wese kuti mutaure neInternational Department of Beijing South Region Oncology Hospital. Chikwata chedu chekurapa chepasi rose chichapa mazano ehunyanzvi, kuongororwa kwezvinyorwa zvekurapa, uye kubatsira mukuona kukodzera kwekutora chikamu mumiedzo yekiriniki iri kuuya.
Ndapota taurai nesu nekukasika kuburikidza nenzira dzinotevera:
Nhare: 400-880-3716
WeChat: 17801183037
Email: 100085_010@163.com | myimmnet@163.com (backup)
Tinonzwisisa kuti mukana wese wekurapwa inyaya yehupenyu netariro. Dhipatimendi reInternational Department reBeijing South Region Oncology Hospital rakazvipira kubatanidza musiyano uripo pakati pevarwere nehunyanzvi hwekurapa hwepamusoro nehunyanzvi hwehunyanzvi uye kutarisirwa kwetsitsi. Ngatitarisirei mberi uye tishande pamwe chete kuti tikunde chirwere ichi.
**Dhipatimendi rePasirose reChipatara cheOncology cheBeijing South Region**
Nhare: 400-880-3716
WeChat: 17801183037
Email: 100085_010@163.com / myimmnet@163.com
Nguva yekutumira: Kurume-17-2026